Abstract:OBJECTIVE:To detect the expression of aquaporin 1 (AQP1) in breast cancer tissues, and to analyze its relationship with clinicopathological characteristics and prognosis of breast cancer patients.METHODS:Histochemical SP staining was used to assess the AQP1 expression in 30 cases of lobular hyperplasia of mammary gland, 16 cases of ductal carcinoma in situ (DCIS), and 78 cases of invasive ductal carcinoma-not otherwise specified (IDC-NOS), and to analyze the relationship between cytoplasmic expression of AQP1 in IDC-NOS and clinical pathological characteristics and prognosis of the patients.RESULTS:Positive AQP1 immunolabelling appeared as brown deposit over the membrane of myoepithelial cells in all cases of lobular hyperplasia of mammary gland, but only 10.0% of cases showed cytoplasmic staining in glandular epithelial cells. In the ductal carcinoma in situ, brown deposit of AQP1 immunolabelling appeared over the myoepithelial cell membrane in all cases, but only 12.5% of cases were accompanied with cytoplasmic staining in glandular epithelial cells. In the invasive ductal carcinoma not otherwise specified, 35.9% of the cases showed cytoplasmic AQP1 immunoreactivity, but only 3.8% of cases showed positive membrane staining of the tumor cells. There were highly positive AQP1 expression in 14 cases, weakly positive in 14 cases, and negative in 50 cases. Cytoplasmic AQP1 expression in the IDC-NOS cases was significantly correlated with pathologic stage, PR, HER-2, lymph node status, Nottingham prognostic index (NPI) and metastasis or recurrence (all P < 0.05). The 5-year progression-free survival (PFS) rates were 16.8% in the patients with strong positive AQP1 expression, 90.9% in the cases with weakly positive AQP1 expression and 94.9% in the AQP1-negative cases, showing a significant difference (P < 0.05). Multivariate analysis indicated that the lymph node status and cytoplasmic expression of AQP1 were independent factors for PFS (both P < 0.05). The 5-year overall survival (OS) rates were 45.6% in the AQP1- strong positive cases, 90.0% in the AQP1-weakly positive cases and 97.7% in the AQP1-negative cases, showing a significant difference (P < 0.05). Multivariate analysis indicated that the lymph node status and cytoplasmic expression of AQP1 were independent factors affecting the overall survival and progression-free survival (both P < 0.05).CONCLUSION:AQP1 is mainly expressed on the membrane of myoepithelial cells in the benign breast lesions, but in the cytoplasm of breast cancer cells, and its expression is an independent factor affecting prognosis of breast cancer patients.

[Cytoplasmic Expression of Aquaporin-1 in Breast Cancer Cells and Its Relationship with Clinicopathological Characteristics and Prognosis].

Expression of Aquaporin1, a Water Channel Protein, in Cytoplasm is Negatively Correlated with Prognosis of Breast Cancer Patients

Expression and Role of AQP1 in Cervical Squamous Carcinoma and Its Precancerous Lesions

The Expression of Aquaporin-1 and Aquaporin-5 in Epithelial Ovarian Tumors and Its Clinic Signifiance.

Significant Prognostic Values of Aquaporin Mrna Expression in Breast Cancer

Expression of Aquaporin 1, 3 and 5 in Colorectal Carcinoma: Correlation with Clinicopathological Characteristics and Prognosis.

AQP1 and AQP3 Expression Are Associated with Severe Symptoms and Poor-prognosis of the Pancreatic Ductal Adenocarcinoma.

Elevated AQP1 Expression is Associated with Unfavorable Oncologic Outcome in Patients with Hilar Cholangiocarcinoma.

Expression of AQP3 and AQP5 As a Prognostic Marker in Triple-Negative Breast Cancer.

Abnormal expression and the significant prognostic value of aquaporins in clear cell renal cell carcinoma

Expression of AQP5 in colorectal cancer and its relationship with clinical outcome

Expression and distribution of AQP1,AQP4 in cervical squamous cell carcinomas.

Over-expression of a Poor Prognostic Marker in Prostate Cancer: AQP5 Promotes Cells Growth and Local Invasion

AQP5: A Novel Biomarker That Predicts Poor Clinical Outcome in Colorectal Cancer

Aquaporin1 Expression in Glioma Patients and Its Potential Func-Tion in Glioma Progression

The Expression of Aquaporin-1 and Aquaporin-3 in Extrahepatic Cholangiocarcinoma and Their Clinicopathological Significance.

The Association Between Aquaporin-1 Expression, Microvessel Density and the Clinicopathological Features of Hepatocellular Carcinoma.

Aquaporin 1 is a prognostic marker and inhibits tumour progression through downregulation of Snail expression in intrahepatic cholangiocarcinoma

Water Channel Protein AQP1 in Cytoplasm is a Critical Factor in Breast Cancer Local Invasion.

Integrated Analysis Identifies AQP9 Correlates with Immune Infiltration and Acts As a Prognosticator in Multiple Cancers.

Expression of Aquaporin-1 in Normal, Hyperplasic, and Carcinomatous Endometria.